What's new

EMEA-002566-PIP01-19-M01

EMEA-002566-PIP01-19-M01

Mar 14, 2025 - 14:19
 0
EMEA-002566-PIP01-19-M01
EMEA-002566-PIP01-19-M01
Read More

Tags:

Previous Article

RFK Jr. says measles vaccine routinely causes deaths. That’s not true

Next Article

Baywa r.e sells 127MW French PV projects repurposing military sites, boosting bi...

Related Posts

Human medicines European public assessment report (EPAR): Nimenrix, meningococcal groups A, C, W-135 and Y conjugate vaccine, Date of authorisation: 20/04/2012, Revision: 41, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 13, 2025  0

Human medicines European public assessment report (EPAR): Erbitux, cetuximab, Date of authorisation: 29/06/2004, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 19, 2025  0

Human medicines European public assessment report (EPAR): Voydeya, Danicopan, Date of authorisation: 19/04/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0